Get the Stockscreener App
1.06
0.00%
0.00
After Hours:
.88
-0.18
-16.98%
Profusa Inc stock is traded at $1.06, with a volume of 1.01M.
It is up +0.00% in the last 24 hours and up +809.87% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
See More
Previous Close:
$1.06
Open:
$1.04
24h Volume:
1.01M
Relative Volume:
0.37
Market Cap:
$561.80K
Revenue:
$75,000
Net Income/Loss:
$-42.41M
P/E Ratio:
-0.00589
EPS:
-179.8206
Net Cash Flow:
$-18.47M
1W Performance:
-38.01%
1M Performance:
+809.87%
6M Performance:
-84.75%
1Y Performance:
-97.98%
1-Day Range:
$0.98
$1.11
1-Week Range:
$0.8608
$1.38
52-Week Range:
$0.0801
$51.90
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
1.06 | 646.60K | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Stock (PFSA) Latest News
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes - Yahoo Finance
Profusa signs term sheet to acquire diagnostics company By Investing.com - Investing.com South Africa
Why Is Profusa Stock Falling Monday? - Benzinga
Profusa Announces CEO Change and Plans to Acquire $111M Diagnostics Company in Major Growth Move 12 - Minichart
Profusa Announces Key Management Changes And Signing Of Non-Binding Term Sheet For The Acquisition Of A Commercial Stage Diagnostics Company - TradingView
Profusa: Ben Hwang Has Transitioned Into the Role of President of Profusa >PFSA - Moomoo
Profusa Plans Strategic Acquisition in Diagnostics Expansion - TipRanks
Profusa signs term sheet to acquire diagnostics company - Investing.com
Profusa (PFSA) pursues diagnostics acquisition and plans $7M convertible financing - Stock Titan
PFSA|Profusa Ord Shs|Price:1.710|Chg%:-0.050 - TradingKey
Profusa Names Jack Stover CEO; Ben Hwang Becomes President - Stock Titan
Profusa, Inc. Revenue Breakdown – NASDAQ:PFSA - TradingView
Profusa Ord Shs (PFSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Enterprise value to revenue forward of PROFUSA, INC. – OTC:NVACW - TradingView
Price to sales forward of PROFUSA, INC. – OTC:NVACW - TradingView
Price to earnings forward of PROFUSA, INC. – OTC:NVACW - TradingView
Strategy, Trump Media, Sequans, Blockchain Group, and Profusa scoop $2.9B BTC off the market - MSN
Profusa approves 1-for-25 reverse stock split; shares tumble - MSN
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year - Stocktwits
Profusa Stock Short Interest Rises to 44.46% - Quiver Quantitative
Profusa files resale prospectus for up to 7,170,891 shares - scanx.trade
Profusa (PFSA) registers 23,194 resale shares; 1-for-25 reverse split cut float - Stock Titan
Profusa (PFSA) registers 7.17M resale shares and effects 1:25 reverse split - Stock Titan
Profusa (NASDAQ: PFSA) registers 22,716-share resale following 1:25 reverse split - Stock Titan
Profusa Announces 1-for-25 Reverse Stock Split Effective July 7, 2026 to Maintain Nasdaq Listing - Minichart
Profusa Implements 1-for-25 Reverse Stock Split on Nasdaq - TipRanks
Profusa (NASDAQ: PFSA) enacts 1-for-25 reverse stock split, cuts share count - Stock Titan
Profusa announces reverse stock split - Medical Buyer
PFSA Should I Buy - Intellectia AI
11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa announces 1-for-25 reverse stock split effective July 7 - Investing.com Australia
Profusa Announces 1-for-25 Reverse Stock Split Effective July 7, 2026 - Quiver Quantitative
Profusa to cut shares 25-to-1 before Nasdaq trading opens July 7 - Stock Titan
Profusa Announces 1-for-25 Reverse Stock Split - The Manila Times
Enterprise value to revenue forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Price to book forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Enterprise value to EBITDA forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Price to earnings forward of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Company Profile & Introduction - Moomoo
Profusa Inc. (PFSA) Slips 9.23% as Stock Tests Key Support at $0.11Buffered ETF - dars.gov.et
At the 2026 annual meeting, Profusa Inc’s shareholders formally approved a series of key strategic initiatives. - Bitget
Which stocks are most active on Wednesday? - ChartMill
Profusa Shareholders Approve Reverse Split and Governance Changes - The Globe and Mail
Profusa shareholders approve acquisition, debt conversion proposals By Investing.com - Investing.com South Africa
Profusa (NASDAQ:PFSA) Advances Biosensing and Diagnostics Expansion - Kalkine Media
Profusa shareholders approve acquisition, debt conversion proposals - Investing.com
Profusa wins shareholder backing for PanOmics deal and Nasdaq push - Stock Titan
Profusa Inc. (PFSA) Plunges 15.97%: Testing Critical Support LevelsBreakout Trade - dars.gov.et
Form 8K Profusa Inc For: 23 June By Investing.com - Investing.com South Africa
Profusa stockholders approve board proposals including director election and reverse split authorization - Investing.com UK
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.04%
11.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):